Vassileva S, Murrell DF, Culton DA, Ujiie H, Hertl M, Goebeler M, Sinha AA, Schmidt E, Stoykov I, Verheesen P, Borradori L, Werth VP, Joly P. Overview of Clinical Trials With Efgartigimod in Autoimmune Blistering Diseases: Pemphigus Vulgaris and Pemphigus Foliaceus (ADDRESS and ADDRESS+) and Bullous Pemphigoid (BALLAD and BALLAD+). J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s345. Available from: https://jofskin.org/33014/index.php/skin/article/view/2348